T. Ishii

发表

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)

H. Nakagawa, K. Sayama, Koichiro Nakamura, 2016, The Journal of dermatology.

Efficacy and safety of open‐label ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis

H. Nakagawa, T. Ishii, M. Heffernan, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer

M. Munakata, T. Ishii, Y. Tanino, 2015, BMC Research Notes.

Validation study of asthma screening criteria based on subjective symptoms and fractional exhaled nitric oxide.

M. Munakata, Suguru Sato, J. Saito, 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough.

M. Munakata, Suguru Sato, J. Saito, 2008, Respiratory Medicine.

Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.

Y. Saeki, H. Onda, I. Kawase, 2005, DNA research : an international journal for rapid publication of reports on genes and genomes.

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

D. M. van der Heijde, M. Weinblatt, E. Keystone, 2017, The New England journal of medicine.

Safety and Effectiveness of Baricitinib for Rheumatoid Arthritis in Japanese Clinical Practice: 24-Week Results of All-Case Post-Marketing Surveillance.

H. Matsuno, N. Tamura, T. Takeuchi, 2022, Modern rheumatology.

Cell Cycle-Dependent Rho GTPase Activity Dynamically Regulates Cancer Cell Motility and Invasion In Vivo

K. Mimori, H. Ishii, Y. Doki, 2013, PloS one.

Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment

M. Genovese, J. Smolen, K. Winthrop, 2018, The Journal of Rheumatology.

Enhanced local production of osteopontin in rheumatoid joints.

Y. Saeki, I. Kawase, H. Matsuno, 2002, The Journal of rheumatology.

Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials

Yoshiya Tanaka, Y. Isaka, J. Smolen, 2020, Modern rheumatology.

A possible mechanism of NK cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) in a patient with chronic active Epstein-Barr virus infection (CAEBV) and severe hypersensitivity to mosquito bites (SHMB).

M. Ishii, Y. Saeki, H. Asada, 2002, Internal medicine.

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic

Yasuhiko Tsukada, J. Saito, T. Ishii, 2021, medRxiv.

Possibility of preventive treatment for EBV-associated NK cell-lineage proliferative disorders.

M. Ishii, Y. Saeki, I. Kawase, 2003, Internal medicine.

Interferon-α Acts on the S/G2/M Phases to Induce Apoptosis in the G1 Phase of an IFNAR2-expressing Hepatocellular Carcinoma Cell Line*

H. Eguchi, H. Ishii, Y. Doki, 2014, The Journal of Biological Chemistry.

Osteopontin as a positive regulator in the osteoclastogenesis of arthritis.

Y. Saeki, I. Kawase, L. Liaw, 2004, Biochemical and biophysical research communications.

A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin‐5

M. Ishii, Y. Saeki, T. Ishii, 2003, European journal of haematology.

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis

Y. Shima, A. Ogata, Toshio Tanaka, 2011, Modern rheumatology.

Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials

Yoshiya Tanaka, T. Takeuchi, T. Ishii, 2018, Modern rheumatology.

Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study

Yoshiya Tanaka, T. Ishii, W. Macias, 2018, Modern rheumatology.

Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation

M. Munakata, Suguru Sato, J. Saito, 2013, European Respiratory Journal.

The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy

M. Ishii, T. Ishii, J. Kikuta, 2011, Molecules and cells.

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)

T. Ishii, R. Nishikomori, N. Kanazawa, 2023, Pediatric Rheumatology.

Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis

D. M. van der Heijde, P. Emery, Yoshiya Tanaka, 2019, RMD Open.

The Use of patient Reported Outcome Measures for Rheumatoid Arthritis in Japan: A Systematic Literature Review

T. Treuer, T. Ishii, B. Crawford, 2017, The open rheumatology journal.

RANKL‐Induced Expression of Tetraspanin CD9 in Lipid Raft Membrane Microdomain Is Essential for Cell Fusion During Osteoclastogenesis

M. Ishii, Y. Saeki, M. Koike, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Antigen induced arthritis (AIA) can be transferred by bone marrow transplantation: evidence that interleukin 6 is essential for induction of AIA.

Y. Saeki, I. Kawase, T. Kishimoto, 2002, The Journal of rheumatology.

Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study

M. Weinblatt, E. Keystone, D. Heijde, 2015 .

[Differences of fractional exhaled nitric oxide (FeNO) levels performed using two different analyzers].

M. Munakata, Suguru Sato, J. Saito, 2010, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Control of osteoclast precursor migration: A novel point of control for osteoclastogenesis and bone homeostasis

M. Ishii, T. Ishii, J. Kikuta, 2010 .

supplement to: Baricitinib versus placebo or adalimumab in rheumatoid arthritis.

D. M. van der Heijde, M. Weinblatt, E. Keystone, 2017 .

Diagnostic usefulness of bronchoalveolar lavage in Hermansky-Pudlak syndrome: a case with double lung cancers.

M. Munakata, Kumi Takahashi, Suguru Sato, 2004, Internal medicine.